TiHo Bibliothek elib - Tierärztliche Hochschule Hannover

Untersuchung des Chemokins MIP-3 β/CCL19
JEFFERY, N.D. (2009):
Pathophysiology of spinal cord injury.
in: 2009 ACVIM Forum, Canadian VMA Convention, Montréal, 318-9.
JEFFERY, N.D., HAMILTON, L., u. GRANGER, N. (2011).
Designing clinical trials in canine spinal cord injury as a model to translate successful
laboratory interventions into clinical practice.
Vet. Rec. 168, 102-7
KIM, C.H., L.M. PELUS, J.R. WHITE, E. APPLEBAUM, K. JOHANSON u.
H.E.BROXMEYER (1998):
Macrophage- inflammatory protein- 3 beta/EBll- ligand chemokine/CK beta- ll, a CC
chemokine, is a chemoattractant with a specificity for macrophages progenitor cells.
J. Immunol. 161, 2580- 2585
KIVISÄKK, P., D. J. MAHAD, M. K. CALLAHAN, K. SIKORA, C. TREBST, B. TUCKY,
J. WUJEK, R. RAVID, S. M. STAUGAITIS, H. LASSMANN u. R. M RANSOHOFF
(2004):
Expression of CCR7 in multiple sclerosis: implications for CNS immunity,
Ann. Neurol. 55, 627-38
KRUMBHOLZ, M., D. THEIL, F. STEINMEYER, S. CEPOK, B. HEMMER, M.
HOFBAUER, C. FARINA, T. DERFUSS, A. JUNKER, T. ARZBERGER, I. SINICINA,
C. HARTLE, J. NEWCOMBE, R. HOHLFELD u. E. MEINL (2007):
CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation,
active and also inactive multiple sclerosis lesions.
J. Neuroimmunol. 190, 72-79
53